{
    "abstract": "A preferred adjuvant should promote both Th1 and Th2 responses. However, most adjuvants in common use are biased towards a Th2-driven response. Therefore, the ability of a novel saponin-based adjuvant G3 to inducing balanced Th1 and Th2 responses in BALB/c mice immunized with a split trivalent seasonal influenza vaccine was evaluated in comparison to that of the adjuvant Al(OH)3. Clear differences in the IgG profiles induced by G3, Al(OH)3 or non-adjuvanted vaccine were recorded. Both adjuvants enhanced high and similar levels of the Th2 associated IgG1 subtype compared to mice given vaccine alone. Only G3 enhanced the IgG2a subclass reflecting a Th1 response, whereas Al(OH)3 even abrogated the IgG2a production. Accordingly, G3 enhanced the production of IL-2 and IFN-\u03b3 and also of IL-2/IFN-\u03b3 double secreting cells, emphasizing the strong Th1 driving effect of G3. Only Al(OH)3 increased splenocyte production of IL-17. Taken together, the results indicate a strong propensity for G3 to induce both Th1 and Th2 driven immune responses.",
    "bib_entries": {
        "b0005": null,
        "b0010": {
            "authors": [
                {
                    "first": "Erik B.",
                    "initial": "E.B.",
                    "last": "Lindblad"
                }
            ],
            "doi": "10.1016/j.vaccine.2004.03.032",
            "firstpage": "3658",
            "issn": "0264410X",
            "lastpage": "3668",
            "pmid": "15315845",
            "pub_year": 2004,
            "title": "Aluminium adjuvants - In retrospect and prospect",
            "volume": "22"
        },
        "b0015": {
            "authors": [
                {
                    "first": "M. J.",
                    "initial": "M.J.",
                    "last": "Newman"
                },
                {
                    "first": "J. Y.",
                    "initial": "J.Y.",
                    "last": "Wu"
                },
                {
                    "first": "B. H.",
                    "initial": "B.H.",
                    "last": "Gardner"
                },
                {
                    "first": "K. J.",
                    "initial": "K.J.",
                    "last": "Munroe"
                },
                {
                    "first": "D.",
                    "initial": "D.",
                    "last": "Leombruno"
                },
                {
                    "first": "J.",
                    "initial": "J.",
                    "last": "Recchia"
                },
                {
                    "first": "C. R.",
                    "initial": "C.R.",
                    "last": "Kensil"
                },
                {
                    "first": "R. T.",
                    "initial": "R.T.",
                    "last": "Coughlin"
                }
            ],
            "firstpage": "2357",
            "issn": "00221767",
            "lastpage": "2362",
            "pmid": "1373166",
            "pub_year": 1992,
            "title": "Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses",
            "volume": "148"
        },
        "b0020": {
            "authors": [
                {
                    "first": "P. D.",
                    "initial": "P.D.",
                    "last": "JONES"
                },
                {
                    "first": "R.",
                    "initial": "R.",
                    "last": "THAHLA"
                },
                {
                    "first": "B.",
                    "initial": "B.",
                    "last": "MOREIN"
                },
                {
                    "first": "K.",
                    "initial": "K.",
                    "last": "LOVGREN"
                },
                {
                    "first": "G. L.",
                    "initial": "G.L.",
                    "last": "ADA"
                }
            ],
            "doi": "10.1111/j.1365-3083.1988.tb02397.x",
            "firstpage": "645",
            "issn": "03009475",
            "lastpage": "652",
            "pmid": "3260681",
            "pub_year": 1988,
            "title": "Cellular Immune Responses in the Murine Lung to Local Immunization with Influenza A Virus Glycoproteins in Micelles and Immunostimulatory Complexes (Iscoms)",
            "volume": "27"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Hidemi",
                    "initial": "H.",
                    "last": "Takahashi"
                },
                {
                    "first": "Toshiyuki",
                    "initial": "T.",
                    "last": "Takeshfta"
                },
                {
                    "first": "Bror",
                    "initial": "B.",
                    "last": "Morein"
                },
                {
                    "first": "Scott",
                    "initial": "S.",
                    "last": "Putney"
                },
                {
                    "first": "Ronald N.",
                    "initial": "R.N.",
                    "last": "Germain"
                },
                {
                    "first": "Jay A.",
                    "initial": "J.A.",
                    "last": "Berzofsky"
                }
            ],
            "doi": "10.1038/344873a0",
            "firstpage": "873",
            "issn": "00280836",
            "lastpage": "875",
            "pmid": "2184369",
            "pub_year": 1990,
            "title": "Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs",
            "volume": "344"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Hong Xiang",
                    "initial": "H.X.",
                    "last": "Sun"
                },
                {
                    "first": "Yong",
                    "initial": "Y.",
                    "last": "Xie"
                },
                {
                    "first": "Yi Ping",
                    "initial": "Y.P.",
                    "last": "Ye"
                }
            ],
            "doi": "10.1016/j.vaccine.2009.01.091",
            "firstpage": "1787",
            "issn": "0264410X",
            "lastpage": "1796",
            "pmid": "19208455",
            "pub_year": 2009,
            "title": "Advances in saponin-based adjuvants",
            "volume": "27"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Karin",
                    "initial": "K.",
                    "last": "L\u00f6vgren Bengtsson"
                },
                {
                    "first": "Bror",
                    "initial": "B.",
                    "last": "Morein"
                },
                {
                    "first": "Albert Dme",
                    "initial": "A.D.",
                    "last": "Osterhaus"
                }
            ],
            "doi": "10.1586/erv.11.25",
            "firstpage": "401",
            "issn": "14760584",
            "lastpage": "403",
            "pmid": "21506635",
            "pub_year": 2011,
            "title": "ISCOM technology-based Matrix M\u2122 adjuvant: Success in future vaccines relies on formulation",
            "volume": "10"
        },
        "b0040": {
            "authors": [
                {
                    "first": "Adriana Baz",
                    "initial": "A.B.",
                    "last": "Morelli"
                },
                {
                    "first": "Dorit",
                    "initial": "D.",
                    "last": "Becher"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Koernig"
                },
                {
                    "first": "Anabel",
                    "initial": "A.",
                    "last": "Silva"
                },
                {
                    "first": "Debbie",
                    "initial": "D.",
                    "last": "Drane"
                },
                {
                    "first": "Eugene",
                    "initial": "E.",
                    "last": "Maraskovsky"
                }
            ],
            "doi": "10.1099/jmm.0.040857-0",
            "firstpage": "935",
            "issn": "00222615",
            "lastpage": "943",
            "pmid": "22442293",
            "pub_year": 2012,
            "title": "ISCOMATRIX: A novel adjuvant for use in prophylactic and therapeutic vaccines against infectious diseases",
            "volume": "61"
        },
        "b0045": {
            "authors": [
                {
                    "first": "Karin L\u00f6vgren",
                    "initial": "K.L.",
                    "last": "Bengtsson"
                },
                {
                    "first": "Karin H.",
                    "initial": "K.H.",
                    "last": "Karlsson"
                },
                {
                    "first": "Sofia E.",
                    "initial": "S.E.",
                    "last": "Magnusson"
                },
                {
                    "first": "Jenny M.",
                    "initial": "J.M.",
                    "last": "Reimer"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Stertman"
                }
            ],
            "doi": "10.1586/14760584.2013.814822",
            "firstpage": "821",
            "issn": "14760584",
            "lastpage": "823",
            "pmid": "23984954",
            "pub_year": 2013,
            "title": "Matrix-M\u2122 adjuvant: Enhancing immune responses by 'setting the stage' for the antigen",
            "volume": "12"
        },
        "b0050": {
            "authors": [
                {
                    "first": "William E.",
                    "initial": "W.E.",
                    "last": "Walkowicz"
                },
                {
                    "first": "Alberto",
                    "initial": "A.",
                    "last": "Fern\u00e1ndez-Tejada"
                },
                {
                    "first": "Constantine",
                    "initial": "C.",
                    "last": "George"
                },
                {
                    "first": "Francisco",
                    "initial": "F.",
                    "last": "Corzana"
                },
                {
                    "first": "Jes\u00fas",
                    "initial": "J.",
                    "last": "Jim\u00e9nez-Barbero"
                },
                {
                    "first": "Govind",
                    "initial": "G.",
                    "last": "Ragupathi"
                },
                {
                    "first": "Derek S.",
                    "initial": "D.S.",
                    "last": "Tan"
                },
                {
                    "first": "David Y.",
                    "initial": "D.Y.",
                    "last": "Gin"
                }
            ],
            "doi": "10.1039/c5sc02978c",
            "firstpage": "2371",
            "issn": "20416520",
            "lastpage": "2380",
            "pub_year": 2016,
            "title": "Quillaja saponin variants with central glycosidic linkage modifications exhibit distinct conformations and adjuvant activities",
            "volume": "7"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Ennio",
                    "initial": "E.",
                    "last": "De Gregorio"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                }
            ],
            "doi": "10.1038/nri3694",
            "firstpage": "505",
            "issn": "14741733",
            "lastpage": "514",
            "pmid": "24925139",
            "pub_year": 2014,
            "title": "From empiricism to rational design: A personal perspective of the evolution of vaccine development",
            "volume": "14"
        },
        "b0060": {
            "authors": [
                {
                    "first": "Derek T.",
                    "initial": "D.T.",
                    "last": "O'Hagan"
                },
                {
                    "first": "Christopher B.",
                    "initial": "C.B.",
                    "last": "Fox"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.01.088",
            "firstpage": "B14",
            "issn": "0264410X",
            "lastpage": "B20",
            "pmid": "26022561",
            "pub_year": 2015,
            "title": "New generation adjuvants - From empiricism to rational design",
            "volume": "33"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Carolien E.",
                    "initial": "C.E.",
                    "last": "van de Sandt"
                },
                {
                    "first": "Joost H.C.M.",
                    "initial": "J.H.C.M.",
                    "last": "Kreijtz"
                },
                {
                    "first": "Martina M.",
                    "initial": "M.M.",
                    "last": "Geelhoed-Mieras"
                },
                {
                    "first": "Stella E.Vogelzang van",
                    "initial": "S.E.V.v.",
                    "last": "Trierum"
                },
                {
                    "first": "Nella J.",
                    "initial": "N.J.",
                    "last": "Nieuwkoop"
                },
                {
                    "first": "David A.M.C.",
                    "initial": "D.A.M.C.",
                    "last": "van de Vijver"
                },
                {
                    "first": "Ron A.M.",
                    "initial": "R.A.M.",
                    "last": "Fouchier"
                },
                {
                    "first": "Albert D.M.E.",
                    "initial": "A.D.M.E.",
                    "last": "Osterhaus"
                },
                {
                    "first": "Bror",
                    "initial": "B.",
                    "last": "Morein"
                },
                {
                    "first": "Guus F.",
                    "initial": "G.F.",
                    "last": "Rimmelzwaan"
                }
            ],
            "doi": "10.1016/j.vaccine.2014.08.003",
            "firstpage": "5614",
            "issn": "0264410X",
            "lastpage": "5623",
            "pmid": "25140929",
            "pub_year": 2014,
            "title": "Novel G3/DT adjuvant promotes the induction of protective T cells responses after vaccination with a seasonal trivalent inactivated split-virion influenza vaccine",
            "volume": "32"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Bungener"
                },
                {
                    "first": "Felix",
                    "initial": "F.",
                    "last": "Geeraedts"
                },
                {
                    "first": "Wouter",
                    "initial": "W.",
                    "last": "ter Veer"
                },
                {
                    "first": "Jeroen",
                    "initial": "J.",
                    "last": "Medema"
                },
                {
                    "first": "Jan",
                    "initial": "J.",
                    "last": "Wilschut"
                },
                {
                    "first": "Anke",
                    "initial": "A.",
                    "last": "Huckriede"
                }
            ],
            "doi": "10.1016/j.vaccine.2008.02.063",
            "firstpage": "2350",
            "issn": "0264410X",
            "lastpage": "2359",
            "pmid": "18400340",
            "pub_year": 2008,
            "title": "Alum boosts TH2-type antibody responses to whole-inactivated virus influenza vaccine in mice but does not confer superior protection",
            "volume": "26"
        },
        "b0075": {
            "authors": [
                {
                    "first": "A. O.",
                    "initial": "A.O.",
                    "last": "Hovden"
                },
                {
                    "first": "R. J.",
                    "initial": "R.J.",
                    "last": "Cox"
                },
                {
                    "first": "L. R.",
                    "initial": "L.R.",
                    "last": "Haaheim"
                }
            ],
            "doi": "10.1111/j.1365-3083.2005.01633.x",
            "firstpage": "36",
            "issn": "03009475",
            "lastpage": "44",
            "pmid": "16092921",
            "pub_year": 2005,
            "title": "Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice",
            "volume": "62"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Caproni"
                },
                {
                    "first": "Elaine",
                    "initial": "E.",
                    "last": "Tritto"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Cortese"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Muzzi"
                },
                {
                    "first": "Flaviana",
                    "initial": "F.",
                    "last": "Mosca"
                },
                {
                    "first": "Elisabetta",
                    "initial": "E.",
                    "last": "Monaci"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "Baudner"
                },
                {
                    "first": "Anja",
                    "initial": "A.",
                    "last": "Seubert"
                },
                {
                    "first": "Ennio",
                    "initial": "E.",
                    "last": "De Gregorio"
                }
            ],
            "doi": "10.4049/jimmunol.1101764",
            "firstpage": "3088",
            "issn": "00221767",
            "lastpage": "3098",
            "pmid": "22351935",
            "pub_year": 2012,
            "title": "MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I-independent mechanism of action",
            "volume": "188"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Andreas",
                    "initial": "A.",
                    "last": "Wack"
                },
                {
                    "first": "Barbara C.",
                    "initial": "B.C.",
                    "last": "Baudner"
                },
                {
                    "first": "Anne K.",
                    "initial": "A.K.",
                    "last": "Hilbert"
                },
                {
                    "first": "Ilaria",
                    "initial": "I.",
                    "last": "Manini"
                },
                {
                    "first": "Sandra",
                    "initial": "S.",
                    "last": "Nuti"
                },
                {
                    "first": "Simona",
                    "initial": "S.",
                    "last": "Tavarini"
                },
                {
                    "first": "Hanno",
                    "initial": "H.",
                    "last": "Scheffczik"
                },
                {
                    "first": "Mildred",
                    "initial": "M.",
                    "last": "Ugozzoli"
                },
                {
                    "first": "Manmohan",
                    "initial": "M.",
                    "last": "Singh"
                },
                {
                    "first": "Jina",
                    "initial": "J.",
                    "last": "Kazzaz"
                },
                {
                    "first": "Emanuele",
                    "initial": "E.",
                    "last": "Montomoli"
                },
                {
                    "first": "Giuseppe",
                    "initial": "G.",
                    "last": "Del Giudice"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Derek T.",
                    "initial": "D.T.",
                    "last": "O'Hagan"
                }
            ],
            "doi": "10.1016/j.vaccine.2007.11.054",
            "firstpage": "552",
            "issn": "0264410X",
            "lastpage": "561",
            "pmid": "18162266",
            "pub_year": 2008,
            "title": "Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice",
            "volume": "26"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Sofia E.",
                    "initial": "S.E.",
                    "last": "Magnusson"
                },
                {
                    "first": "Jenny M.",
                    "initial": "J.M.",
                    "last": "Reimer"
                },
                {
                    "first": "Karin H.",
                    "initial": "K.H.",
                    "last": "Karlsson"
                },
                {
                    "first": "Lena",
                    "initial": "L.",
                    "last": "Lilja"
                },
                {
                    "first": "Karin L\u00f6vgren",
                    "initial": "K.L.",
                    "last": "Bengtsson"
                },
                {
                    "first": "Linda",
                    "initial": "L.",
                    "last": "Stertman"
                }
            ],
            "doi": "10.1016/j.vaccine.2013.01.039",
            "firstpage": "1725",
            "issn": "0264410X",
            "lastpage": "1733",
            "pmid": "23384754",
            "pub_year": 2013,
            "title": "Immune enhancing properties of the novel Matrix-M\u2122 adjuvant leads to potentiated immune responses to an influenza vaccine in mice",
            "volume": "31"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Peter J.M.",
                    "initial": "P.J.M.",
                    "last": "Openshaw"
                },
                {
                    "first": "Fiona J.",
                    "initial": "F.J.",
                    "last": "Culley"
                },
                {
                    "first": "Wieslawa",
                    "initial": "W.",
                    "last": "Olszewska"
                }
            ],
            "doi": "10.1016/S0264-410X(01)00301-2",
            "firstpage": "S27",
            "issn": "0264410X",
            "lastpage": "S31",
            "pmid": "11587806",
            "pub_year": 2001,
            "title": "Immunopathogenesis of vaccine-enhanced RSV disease",
            "volume": "20"
        },
        "b0100": {
            "authors": [
                {
                    "first": "Philip",
                    "initial": "P.",
                    "last": "Bejon"
                },
                {
                    "first": "Sheila",
                    "initial": "S.",
                    "last": "Keating"
                },
                {
                    "first": "Jedidah",
                    "initial": "J.",
                    "last": "Mwacharo"
                },
                {
                    "first": "Oscar K.",
                    "initial": "O.K.",
                    "last": "Kai"
                },
                {
                    "first": "Susanna",
                    "initial": "S.",
                    "last": "Dunachie"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Walther"
                },
                {
                    "first": "Tamara",
                    "initial": "T.",
                    "last": "Berthoud"
                },
                {
                    "first": "Trudie",
                    "initial": "T.",
                    "last": "Lang"
                },
                {
                    "first": "Judy",
                    "initial": "J.",
                    "last": "Epstein"
                },
                {
                    "first": "Daniel",
                    "initial": "D.",
                    "last": "Carucci"
                },
                {
                    "first": "Philippe",
                    "initial": "P.",
                    "last": "Moris"
                },
                {
                    "first": "Joe",
                    "initial": "J.",
                    "last": "Cohen"
                },
                {
                    "first": "Sarah C.",
                    "initial": "S.C.",
                    "last": "Gilbert"
                },
                {
                    "first": "Norbert",
                    "initial": "N.",
                    "last": "Peshu"
                },
                {
                    "first": "Kevin",
                    "initial": "K.",
                    "last": "Marsh"
                },
                {
                    "first": "Adrian V.S.",
                    "initial": "A.V.S.",
                    "last": "Hill"
                }
            ],
            "doi": "10.1128/IAI.00774-06",
            "firstpage": "6331",
            "issn": "00199567",
            "lastpage": "6338",
            "pmid": "16966412",
            "pub_year": 2006,
            "title": "Early gamma interferon and interleukin-2 responses to vaccination predict the late resting memory in malaria-na\u00efve and malaria-exposed individuals",
            "volume": "74"
        },
        "b0105": {
            "authors": [
                {
                    "first": "Patricia A.",
                    "initial": "P.A.",
                    "last": "Darrah"
                },
                {
                    "first": "Dipti T.",
                    "initial": "D.T.",
                    "last": "Patel"
                },
                {
                    "first": "Paula M.",
                    "initial": "P.M.",
                    "last": "De Luca"
                },
                {
                    "first": "Ross W.B.",
                    "initial": "R.W.B.",
                    "last": "Lindsay"
                },
                {
                    "first": "Dylan F.",
                    "initial": "D.F.",
                    "last": "Davey"
                },
                {
                    "first": "Barbara J.",
                    "initial": "B.J.",
                    "last": "Flynn"
                },
                {
                    "first": "S\u00f8ren T.",
                    "initial": "S.T.",
                    "last": "Hoff"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Andersen"
                },
                {
                    "first": "Steven G.",
                    "initial": "S.G.",
                    "last": "Reed"
                },
                {
                    "first": "Sheldon L.",
                    "initial": "S.L.",
                    "last": "Morris"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Roederer"
                },
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Seder"
                }
            ],
            "doi": "10.1038/nm1592",
            "firstpage": "843",
            "issn": "10788956",
            "lastpage": "850",
            "pmid": "17558415",
            "pub_year": 2007,
            "title": "Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major",
            "volume": "13"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Robert A.",
                    "initial": "R.A.",
                    "last": "Seder"
                },
                {
                    "first": "Patricia A.",
                    "initial": "P.A.",
                    "last": "Darrah"
                },
                {
                    "first": "Mario",
                    "initial": "M.",
                    "last": "Roederer"
                }
            ],
            "doi": "10.1038/nri2274",
            "firstpage": "247",
            "issn": "14741733",
            "lastpage": "258",
            "pmid": "18323851",
            "pub_year": 2008,
            "title": "T-cell quality in memory and protection: Implications for vaccine design",
            "volume": "8"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Jinfang",
                    "initial": "J.",
                    "last": "Zhu"
                },
                {
                    "first": "Hidehiro",
                    "initial": "H.",
                    "last": "Yamane"
                },
                {
                    "first": "William E.",
                    "initial": "W.E.",
                    "last": "Paul"
                }
            ],
            "doi": "10.1146/annurev-immunol-030409-101212",
            "firstpage": "445",
            "issn": "07320582",
            "lastpage": "489",
            "pmid": "20192806",
            "pub_year": 2010,
            "title": "Differentiation of effector CD4+ T cell populations",
            "volume": "28"
        },
        "b0120": null,
        "b0125": {
            "authors": [
                {
                    "first": "Jodi F.",
                    "initial": "J.F.",
                    "last": "Hedges"
                },
                {
                    "first": "Jeff",
                    "initial": "J.",
                    "last": "Holderness"
                },
                {
                    "first": "Mark A.",
                    "initial": "M.A.",
                    "last": "Jutila"
                }
            ],
            "doi": "10.1016/j.vetimm.2016.03.010",
            "firstpage": "30",
            "issn": "01652427",
            "lastpage": "38",
            "pmid": "27021513",
            "pub_year": 2016,
            "title": "Adjuvant materials that enhance bovine \u03b3\u03b4 T cell responses",
            "volume": "181"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Asher",
                    "initial": "A.",
                    "last": "Maroof"
                },
                {
                    "first": "Yvonne M.",
                    "initial": "Y.M.",
                    "last": "Yorgensen"
                },
                {
                    "first": "Yufeng",
                    "initial": "Y.",
                    "last": "Li"
                },
                {
                    "first": "Jay T.",
                    "initial": "J.T.",
                    "last": "Evans"
                }
            ],
            "doi": "10.1371/journal.ppat.1003875",
            "issn": "15537366",
            "pmid": "24465206",
            "pub_year": 2014,
            "title": "Intranasal Vaccination Promotes Detrimental Th17-Mediated Immunity against Influenza Infection",
            "volume": "10"
        },
        "b0135": {
            "authors": [
                {
                    "first": "K. Kai",
                    "initial": "K.K.",
                    "last": "McKinstry"
                },
                {
                    "first": "Tara M.",
                    "initial": "T.M.",
                    "last": "Strutt"
                },
                {
                    "first": "Amanda",
                    "initial": "A.",
                    "last": "Buck"
                },
                {
                    "first": "Jonathan D.",
                    "initial": "J.D.",
                    "last": "Curtis"
                },
                {
                    "first": "John P.",
                    "initial": "J.P.",
                    "last": "Dibble"
                },
                {
                    "first": "Gail",
                    "initial": "G.",
                    "last": "Huston"
                },
                {
                    "first": "Michael",
                    "initial": "M.",
                    "last": "Tighe"
                },
                {
                    "first": "Hiromasa",
                    "initial": "H.",
                    "last": "Hamada"
                },
                {
                    "first": "Stewart",
                    "initial": "S.",
                    "last": "Sell"
                },
                {
                    "first": "Richard W.",
                    "initial": "R.W.",
                    "last": "Dutton"
                },
                {
                    "first": "Susan L.",
                    "initial": "S.L.",
                    "last": "Swain"
                }
            ],
            "doi": "10.4049/jimmunol.0900657",
            "firstpage": "7353",
            "issn": "00221767",
            "lastpage": "7363",
            "pmid": "19494257",
            "pub_year": 2009,
            "title": "IL-10 deficiency unleashes an influenza-specific Th17 response and enhances survival against high-dose challenge",
            "volume": "182"
        },
        "b0140": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Zeng"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Nourishirazi"
                },
                {
                    "first": "E.",
                    "initial": "E.",
                    "last": "Guinet"
                },
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Nouri-Shirazi"
                }
            ],
            "doi": "10.1111/cei.12841",
            "firstpage": "190",
            "issn": "00099104",
            "lastpage": "204",
            "pmid": "27393001",
            "pub_year": 2016,
            "title": "The genetic background influences the cellular and humoral immune responses to vaccines",
            "volume": "186"
        }
    },
    "body_text": [
        {
            "endOffset": 19164,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The Flu-Al(OH)3 group displayed slightly less total Ig than the Flu-G3 group but more than the group receiving Flu without adjuvant (Fig. 1A).",
            "startOffset": 19022,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        },
        {
            "endOffset": 15086,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Wells were washed (3x) with PBS containing 0.05% Tween 20 between each step.",
            "startOffset": 15010,
            "title": "ELISA"
        },
        {
            "endOffset": 21363,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Splenocytes producing IL-2 were observed at higher frequencies in mice immunized with Flu-Al(OH)3 compared to Flu alone whereas three of the mice in the Flu-G3 group (Nos. 4\u20136) displayed similar numbers of IL-2 secreting cells as the Flu only mice and the other three (Nos. 1\u20133) as the Flu-Al(OH)3 group (Fig. 3B).",
            "startOffset": 21049,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 22451,
            "parents": [],
            "secId": "s0065",
            "sentence": "However, split virus vaccines elicit low levels of protection by its own accord and would benefit from an adjuvant boosting existing immune response.",
            "startOffset": 22302,
            "title": "Discussion"
        },
        {
            "endOffset": 21942,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There was no difference between immunization treatments in the number of cytokine secreting cells after polyclonal induction with ConA, regardless of cytokine tested for (data not shown).",
            "startOffset": 21755,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 11749,
            "parents": [],
            "refoffsets": {
                "b0055": {
                    "endOffset": 11748,
                    "startOffset": 11741
                },
                "b0060": {
                    "endOffset": 11748,
                    "startOffset": 11741
                }
            },
            "secId": "s0005",
            "sentence": "In parallel, many other adjuvant formulations and delivery systems are being designed to improve the immune response to a variety of antigen constructs [11,12].",
            "startOffset": 11589,
            "title": "Introduction"
        },
        {
            "endOffset": 16824,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The plates were coated with monoclonal antibodies, mAbs (15 \u03bcg/ml of each mAb in sterile PBS) for the following cytokines and cytokine combinations; IL-4 (mAb 11B11), IFN-\u03b3/IL-2 (mAbs AN18/1A12), IFN-\u03b3/IL-5 (mAbs AN18/TRFK5), IFN-\u03b3/IL-17 (mAbs AN18/IL17-I) (Mabtech, Nacka Strand, Sweden) and incubated at 4 \u00b0C overnight.",
            "startOffset": 16503,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 12773,
            "parents": [],
            "secId": "s0005",
            "sentence": "For full use of the versatility of G3 we need a better understanding of its immune modulating capacity, including B and T-cell responses.",
            "startOffset": 12636,
            "title": "Introduction"
        },
        {
            "endOffset": 18871,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0045",
            "sentence": "Statistical differences between experimental groups were determined using the Mann-Whitney test (Prism.5.0 Graph Pad Software).",
            "startOffset": 18744,
            "title": "Statistical analysis"
        },
        {
            "endOffset": 15951,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The splenocytes were washed twice in cell culture medium (RPMI 1640, 10% heat-inactivated fetal calf serum (FCS), 1 mM glutamine, 100 units/ml penicillin, 100 \u03bcg/ml streptomycin and 0.5 mM HEPES; Invitrogen Life Technologies, Carlsbad, CA, USA), counted, and checked for viability using a Guava ViaCount Assay (Guava Technologies, Hayward, CA, USA) before dilution to appropriate cell concentrations.",
            "startOffset": 15551,
            "title": "Preparation of mouse splenocytes"
        },
        {
            "endOffset": 11041,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 11040,
                    "startOffset": 11035
                },
                "b0010": {
                    "endOffset": 11040,
                    "startOffset": 11035
                }
            },
            "secId": "s0005",
            "sentence": "However, aluminium compounds have limitations, mainly providing antibody-mediated immunity in accordance with a T helper cell type 2 (Th2) profile [1,2].",
            "startOffset": 10888,
            "title": "Introduction"
        },
        {
            "endOffset": 20814,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "A low percentage (<0.01%) of the splenocytes produced both IL-5 and IFN-\u03b3, regardless of immunization regime.",
            "startOffset": 20705,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 26455,
            "parents": [],
            "secId": "s0070",
            "sentence": "BM developed the G3 adjuvant (Patent No. WO 2013/051994 April 2013).",
            "startOffset": 26387,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 24846,
            "parents": [],
            "secId": "s0065",
            "sentence": "The use of 3 \u00b5g G3 in the present study might be suboptimal and could explain the variation in the IgG1 levels and cells producing IFN- \u03b3 and IL-2.",
            "startOffset": 24699,
            "title": "Discussion"
        },
        {
            "endOffset": 20520,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "A similar pattern was observed for IL-5 (Fig. 2B), with less IL-5 secreting splenocytes obtained from mice immunized with Flu adjuvanted with G3 than when adjuvanted with Al(OH)3.",
            "startOffset": 20341,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 17439,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After incubation at 37 \u00b0C and 5% CO2 for 40 h, cells were removed by washing the plates five times with PBS in an automated ELISA washer (Bio-Tek Instruments Inc., Winooski, VT, USA).",
            "startOffset": 17256,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 25868,
            "parents": [],
            "secId": "s0065",
            "sentence": "Taken together, the split Flu vaccine on its own induced a slightly Th2 biased immune profile that was emphasised when Al(OH)3 was included as adjuvant.",
            "startOffset": 25716,
            "title": "Discussion"
        },
        {
            "endOffset": 25005,
            "parents": [],
            "secId": "s0065",
            "sentence": "Despite that, the overall data from the two studies are in good agreement and the present results show a uniform IgG2a response in mice immunized with Flu-G3.",
            "startOffset": 24847,
            "title": "Discussion"
        },
        {
            "endOffset": 18721,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "To obtain the number of cytokine-secreting cells specifically activated by antigen, the number of spots in control wells with only cells in medium were subtracted.",
            "startOffset": 18558,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 10729,
            "parents": [],
            "secId": "s0005",
            "sentence": "Non-replicative vaccines are in general poorly immunogenic therefore demanding immune enhancement i.e., adjuvants.",
            "startOffset": 10615,
            "title": "Introduction"
        },
        {
            "endOffset": 17255,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The blocking medium was removed and fresh medium with or without stimuli was added (50 \u00b5l/well) followed by addition of fresh splenocytes (100 \u00b5l/well; 250 000 cells/well for antigen-specific analysis (Flu 1 \u00b5g/ml) and medium control and 100 000 cells/well for polyclonal (ConA 5 \u00b5g/ml) activated cells).",
            "startOffset": 16951,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 20202,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The adjuvant effect of G3 and Al(OH)3 was further analyzed by ELISpot (IL-4) and FluoroSpot (IL-2, IL-5, IL-17 and IFN-\u03b3) assays.",
            "startOffset": 20073,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 22780,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 22779,
                    "startOffset": 22772
                },
                "b0085": {
                    "endOffset": 22779,
                    "startOffset": 22772
                }
            },
            "secId": "s0065",
            "sentence": "Particulate adjuvants, such as Al(OH)3 or M59, shift this immune response towards IgG1 whereas some TLR agonists can favor a IgG2a response [16,17].",
            "startOffset": 22632,
            "title": "Discussion"
        },
        {
            "endOffset": 14208,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The mice were immunized twice, 5 weeks apart.",
            "startOffset": 14163,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 23424,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 23423,
                    "startOffset": 23419
                }
            },
            "secId": "s0065",
            "sentence": "These adjuvant effects on IgG subclass distribution are in line with those obtained for split Flu vaccine adjuvanted with another Quil A based adjuvant, Matrix-MTM, or aluminium hydroxide [18].",
            "startOffset": 23231,
            "title": "Discussion"
        },
        {
            "endOffset": 19635,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Mouse No. 6 in the Flu-G3 group and mice Nos. 5 and 6 in the Flu-Al(OH)3 group were outliers in their respective group displaying lower IgG1 titers than the other mice.",
            "startOffset": 19467,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        },
        {
            "endOffset": 22127,
            "parents": [],
            "secId": "s0065",
            "sentence": "A new nanoparticular adjuvant, G3, composed of Quillaja saponin and cholesterol was here analyzed for its immune modulating capacity using a commercial split influenza virus.",
            "startOffset": 21953,
            "title": "Discussion"
        },
        {
            "endOffset": 25076,
            "parents": [],
            "secId": "s0065",
            "sentence": "Al(OH)3 induced elevated levels of the pro-inflammatory cytokine IL-17.",
            "startOffset": 25005,
            "title": "Discussion"
        },
        {
            "endOffset": 16502,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "No. S5EJ104I07; Millipore, Bedford, MA, USA) were pre-wetted with 15 \u03bcl/well of 35% ethanol in water for no more than one minute, and washed five times with sterile water.",
            "startOffset": 16331,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 21582,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Splenocytes secreting both IFN-\u03b3 and IL-2 (Fig. 3C) were scarce in the Flu and Flu-Al(OH)3 groups, whereas splenocytes obtained from mice in the Flu-G3 group showed significantly more IFN-\u03b3/IL-2 double secreting cells.",
            "startOffset": 21364,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 10887,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 10886,
                    "startOffset": 10883
                }
            },
            "secId": "s0005",
            "sentence": "The most used adjuvants are aluminium compounds, being the market leader for both animal and human vaccines, with documented effects and safety profiles [1].",
            "startOffset": 10730,
            "title": "Introduction"
        },
        {
            "endOffset": 12478,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 12477,
                    "startOffset": 12473
                }
            },
            "secId": "s0005",
            "sentence": "The around 20 nm sized G3 particles are formed via an initial hydrogen bond between the hydroxyl group of cholesterol and the carboxyl group in glucuronic acid in the Quil A micelle and a subsequent hydrophobic interaction between sterol and the triterpene of Quil A. G3 combined with proteins from a split influenza vaccine induced high levels of antibodies and the further addition of a third component, a diterpene, induced CD8+CD3+ T-cells and protection against challenge with a H1N1 virus lacking compatible HI and VN antigenic determinants [13].",
            "startOffset": 11926,
            "title": "Introduction"
        },
        {
            "endOffset": 23646,
            "parents": [],
            "secId": "s0065",
            "sentence": "In agreement with the IgG subclass typing, the cytokine response to the G3 vaccine was clearly oriented towards IFN-\u03b3 production whereas Al(OH)3 promoted a pronounced IL-4 and IL-5 production and a slight IL-17 production.",
            "startOffset": 23424,
            "title": "Discussion"
        },
        {
            "endOffset": 18557,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Plates were read and analyzed in an ELISpot/FluoroSpot reader system (iSpot Spectrum, AID, Strassberg, Germany).",
            "startOffset": 18445,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 23007,
            "parents": [],
            "secId": "s0065",
            "sentence": "G3 induced both IgG1 and IgG2a antibodies to higher levels than the non-adjuvanted Flu vaccine.",
            "startOffset": 22912,
            "title": "Discussion"
        },
        {
            "endOffset": 18297,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Substrate was developed for approximately 15 min at RT after which the plates were washed extensively in tap water and left to dry.",
            "startOffset": 18166,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 25402,
            "parents": [],
            "refoffsets": {
                "b0125": {
                    "endOffset": 25401,
                    "startOffset": 25397
                }
            },
            "secId": "s0065",
            "sentence": "In other species such as pigs and cattle IL-17 is also attributed to \u03b3\u03b4 T cells that are much more frequent in these species and tempting targets for innate immunity enhancement [25].",
            "startOffset": 25219,
            "title": "Discussion"
        },
        {
            "endOffset": 18444,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The enhancer was incubated for 15 min before discarded and after removal of the plate underdrain the plates were left to dry protected from light.",
            "startOffset": 18298,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 24698,
            "parents": [],
            "secId": "s0065",
            "sentence": "Furthermore, the previous vaccination study in mice using Flu adjuvanted with 1, 2.5 or 5 \u00b5g G3 (Patent No. WO 2013/051994) showed a dose dependent increase in HI titers and IFN-\u03b3 producing cells while there was no effect on the number of IL-4 producing cells.",
            "startOffset": 24438,
            "title": "Discussion"
        },
        {
            "endOffset": 26264,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 26263,
                    "startOffset": 26259
                }
            },
            "secId": "s0065",
            "sentence": "The present results obtained in BALB/c mice corroborate the earlier study in which G3 induced a protective T-cell response against influenza in C57BL/6J mice [13].",
            "startOffset": 26101,
            "title": "Discussion"
        },
        {
            "endOffset": 22631,
            "parents": [],
            "refoffsets": {
                "b0075": {
                    "endOffset": 22630,
                    "startOffset": 22626
                }
            },
            "secId": "s0065",
            "sentence": "The immune reaction to inactivated whole influenza virus is characterized by an IgG2a response whereas inactivated split virus induce a more mixed IgG2a/IgG1 subclass profile [15].",
            "startOffset": 22451,
            "title": "Discussion"
        },
        {
            "endOffset": 15550,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Spleens were minced and passed through a cell strainer (BD/Falcon, Becton Drive Franklin Lakes, NJ, USA).",
            "startOffset": 15445,
            "title": "Preparation of mouse splenocytes"
        },
        {
            "endOffset": 16129,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Secretion of IL-4 was analyzed in ELISpot while simultaneous secretion of IFN-\u03b3/IL-2, IFN-\u03b3/IL-5 and IFN-\u03b3/IL-17 was analyzed using the FluoroSpot assay.",
            "startOffset": 15976,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 18165,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "After incubation at RT for 1 h plates were washed as above and 100 \u00b5l of BCIP/NBT substrate (ELISpot) or 50 \u03bcl fluorescence enhancer (FluoroSpot) was added to each well.",
            "startOffset": 17996,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 20340,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The numbers of IL-4 secreting cells (Fig. 2A) from the mice given Flu-Al(OH)3 were significantly higher than those for mice given Flu-G3.",
            "startOffset": 20203,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 25542,
            "parents": [],
            "secId": "s0065",
            "sentence": "In fact, preliminary results show transcription of IL-17A in short-term cultures of porcine PBMC exposed to G3 (manuscript in preparation).",
            "startOffset": 25403,
            "title": "Discussion"
        },
        {
            "endOffset": 26367,
            "parents": [],
            "refoffsets": {
                "b0140": {
                    "endOffset": 26366,
                    "startOffset": 26362
                }
            },
            "secId": "s0065",
            "sentence": "Thus, G3 has similar effects in mice genetically predisposed to different T helper cell profiles [28].",
            "startOffset": 26265,
            "title": "Discussion"
        },
        {
            "endOffset": 11232,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 11231,
                    "startOffset": 11228
                }
            },
            "secId": "s0005",
            "sentence": "Early experiments showed that the inability of aluminium salts to induce cytotoxic T lymphocytes (CTL) was overcome by incorporation of a Quillaja saponaria Molina component i.e., QS-21 [3].",
            "startOffset": 11042,
            "title": "Introduction"
        },
        {
            "endOffset": 14341,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Spleens were collected 7 days after the last immunization.",
            "startOffset": 14283,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 19021,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Flu-specific antibodies were detected in all three groups of immunized mice.",
            "startOffset": 18945,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        },
        {
            "endOffset": 14656,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "After blocking (1% milk powder in PBS) for 1 h at RT, sera were added at 1:100, 1:1 000, 1:10 000 and 1:100 000 dilutions and incubated for two hours at RT.",
            "startOffset": 14500,
            "title": "ELISA"
        },
        {
            "endOffset": 13765,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "One \u03bcg Flu antigen was either mixed with a saponin adjuvant \u201cG3\u201d consisting of cholesterol and Quil A (Brenntag Biosector A/S, Fredrikssund, Denmark) formulated in 20 nm particles (MoreinX AB, Uppsala, Sweden) or with an Aluminium hydroxide gel (Alhydrogel\u00ae adjuvant 2%; Invivogen, San Diego, CA, USA), according to the manufacturer\u2019s instructions.",
            "startOffset": 13417,
            "title": "Antigen and adjuvants"
        },
        {
            "endOffset": 11588,
            "parents": [],
            "refoffsets": {
                "b0030": {
                    "endOffset": 11587,
                    "startOffset": 11581
                },
                "b0035": {
                    "endOffset": 11587,
                    "startOffset": 11581
                },
                "b0040": {
                    "endOffset": 11587,
                    "startOffset": 11581
                },
                "b0045": {
                    "endOffset": 11587,
                    "startOffset": 11581
                },
                "b0050": {
                    "endOffset": 11587,
                    "startOffset": 11581
                }
            },
            "secId": "s0005",
            "sentence": "The relationship between adjuvant activity, composition and side effects of Quillaja saponins has been extensively evaluated focusing on QS-21 and ISCOMs [6\u201310].",
            "startOffset": 11427,
            "title": "Introduction"
        },
        {
            "endOffset": 21755,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "The two mice in the Flu-G3 group that displayed most IFN-\u03b3/IL-2 double producing cells (Nos. 2 and 3) also had the highest numbers of IFN-\u03b3 and IL-2 single producing cells.",
            "startOffset": 21583,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 13416,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0015",
            "sentence": "A split trivalent (A/California/7/2009 (H1N1) pdm09-derived strain; A/Texas/50/2012 (H3N2)-derived strain; B/Massachusetts/2/2012) influenza (Flu) vaccine (Vaxigrip 2014/2015; Sanofi Pasteur MSD, Diegem, Belgium) was used for immunization.",
            "startOffset": 13177,
            "title": "Antigen and adjuvants"
        },
        {
            "endOffset": 15009,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "The reactions were stopped after 10 min with 100 \u00b5l 1 M HCl and A450 determined in an ELISA reader (Multiscan Ex, Labsystems).",
            "startOffset": 14883,
            "title": "ELISA"
        },
        {
            "endOffset": 23230,
            "parents": [],
            "secId": "s0065",
            "sentence": "In fact, Al(OH)3 even abrogated the IgG2a response induced by the non-adjuvanted Flu vaccine.",
            "startOffset": 23137,
            "title": "Discussion"
        },
        {
            "endOffset": 16191,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The tests were set up in duplicates under sterile conditions.",
            "startOffset": 16130,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 20704,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "Only a low number of splenocytes secreted IL-17 (Fig. 2C) and only mice immunized with Flu-Al(OH)3 had significantly more IL-17 secreting cells than mice in any other treatment group.",
            "startOffset": 20521,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 24082,
            "parents": [],
            "secId": "s0065",
            "sentence": "However, cells secreting both IFN-\u03b3 and IL-2 were only detected in splenocytes from mice immunized with Flu-G3.",
            "startOffset": 23971,
            "title": "Discussion"
        },
        {
            "endOffset": 16330,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Low fluorescent 96-well PVDF membrane plates (Cat.",
            "startOffset": 16280,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 19316,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "The groups of mice given Flu adjuvanted with G3 or Al(OH)3 responded with similar levels of IgG1 but showed high variation within each group (Fig. 1B).",
            "startOffset": 19165,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        },
        {
            "endOffset": 23819,
            "parents": [],
            "refoffsets": {
                "b0095": {
                    "endOffset": 23818,
                    "startOffset": 23814
                }
            },
            "secId": "s0065",
            "sentence": "G3 downregulated the production of IL-5, a potentially useful property to avoid vaccine-driven eosinophilic immunopathogenesis as described following RSV immunization [19].",
            "startOffset": 23647,
            "title": "Discussion"
        },
        {
            "endOffset": 17787,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Detection antibodies diluted in PBS with 0.1% bovine serum albumin (PBS/BSA); biotinylated anti-IL-4 (1 \u00b5g/ml; mAbs BVD6-24G2), BAM-tagged anti-IFN-\u03b3 (mAb R4-6A2 diluted 1:200), biotinylated antibodies to IL-2 (mAb 5H4), IL-5 (mAb TRFK4), IL-17 (mAb MT2270) all diluted to 2 \u03bcg/ml (Mabtech) were added to the plates and incubated for 90 min at RT.",
            "startOffset": 17440,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 21048,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "In contrast, three of the mice vaccinated with Flu-G3 showed a substantial increase in IFN-\u03b3 secreting cells (Fig. 3A).",
            "startOffset": 20929,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 14282,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Sera were collected before first immunization and after 2, 5 and 6 weeks.",
            "startOffset": 14209,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 23970,
            "parents": [],
            "secId": "s0065",
            "sentence": "Five days after booster immunization more IL-2 secreting cells were detected in splenocytes obtained from mice immunized with Flu-Al(OH)3 than Flu-G3.",
            "startOffset": 23820,
            "title": "Discussion"
        },
        {
            "endOffset": 25716,
            "parents": [],
            "refoffsets": {
                "b0130": {
                    "endOffset": 25715,
                    "startOffset": 25708
                },
                "b0135": {
                    "endOffset": 25715,
                    "startOffset": 25708
                }
            },
            "secId": "s0065",
            "sentence": "Whether inducing IL-17 is beneficial in influenza virus vaccination is controversial as it has been shown to have both exacerbating and protecting qualities in mice [26,27].",
            "startOffset": 25543,
            "title": "Discussion"
        },
        {
            "endOffset": 24437,
            "parents": [],
            "secId": "s0065",
            "sentence": "In accordance, results from transcriptional studies on equine and porcine PBMC stimulated in vitro with G3 consistently show an up-regulation of Th1-associated cytokines including IFNG (manuscripts in preparation).",
            "startOffset": 24223,
            "title": "Discussion"
        },
        {
            "endOffset": 19466,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "For most of these mice the IgG1 response, as well as the HI titers (data not shown) were higher than those for mice receiving non-adjuvanted antigen.",
            "startOffset": 19317,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        },
        {
            "endOffset": 12942,
            "parents": [],
            "secId": "s0005",
            "sentence": "Here we aimed at exploring the immune profile induced by a split influenza vaccine as antigen when adjuvanted with G3 in comparison to the adjuvant aluminium hydroxide.",
            "startOffset": 12774,
            "title": "Introduction"
        },
        {
            "endOffset": 26100,
            "parents": [],
            "secId": "s0065",
            "sentence": "G3 on the other hand, promoted an enhanced balanced Th1/Th2 response as indicated by the IgG2a isotype switch, diminished IL-5 secreting splenocytes and an increased IFN-\u03b3 response including dually IFN-\u03b3/IL-2 secreting splenocytes.",
            "startOffset": 25869,
            "title": "Discussion"
        },
        {
            "endOffset": 23136,
            "parents": [],
            "secId": "s0065",
            "sentence": "In contrast, Al(OH)3 enhanced the IgG1 antibody response to a similar level as G3, but failed to induce a proper IgG2a response.",
            "startOffset": 23008,
            "title": "Discussion"
        },
        {
            "endOffset": 11426,
            "parents": [],
            "refoffsets": {
                "b0020": {
                    "endOffset": 11425,
                    "startOffset": 11420
                },
                "b0025": {
                    "endOffset": 11425,
                    "startOffset": 11420
                }
            },
            "secId": "s0005",
            "sentence": "Likewise, purified viral envelope proteins incorporated into a matrix of the Quillaja component A (Quil A), cholesterol and phospholipids, i.e. ISCOMs, induced CD8+ antigen-specific CTLs [4,5].",
            "startOffset": 11233,
            "title": "Introduction"
        },
        {
            "endOffset": 24222,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 24173,
                    "startOffset": 24166
                },
                "b0105": {
                    "endOffset": 24173,
                    "startOffset": 24166
                },
                "b0110": {
                    "endOffset": 24173,
                    "startOffset": 24166
                }
            },
            "secId": "s0065",
            "sentence": "Such double-secreting cells are likely to promote the generation of memory T cells [20\u201322], an important attribute for a vaccine construct.",
            "startOffset": 24083,
            "title": "Discussion"
        },
        {
            "endOffset": 11925,
            "parents": [],
            "secId": "s0005",
            "sentence": "G3, a new generation of adjuvant consisting of two components, i.e., Quil A and cholesterol, is formulated with a new artificial membrane technique (Patent No. WO 2013/051994).",
            "startOffset": 11749,
            "title": "Introduction"
        },
        {
            "endOffset": 14499,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Flat bottom Maxisorp plates (Nunc) were coated over night at 4 \u00b0C with 0.12 \u00b5g antigen (Vaxigrip 2015\u20132016) in 100 \u00b5l 50 mM Tris-Cl (pH 9.5) per well.",
            "startOffset": 14349,
            "title": "ELISA"
        },
        {
            "endOffset": 14162,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "The mice were divided into four groups (n = 6) and immunized subcutaneously with 200 \u00b5l volumes of; Flu in 3 \u03bcg G3 (Flu-G3); Flu in 100 \u03bcl Alhydrogel\u00ae (Flu-Al(OH)3); Flu in PBS (Flu) or only PBS.",
            "startOffset": 13967,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 19886,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "G3 enhanced the serum levels of IgG2a to Flu (Fig. 1C) significantly whereas the mice administered Flu-Al(OH)3 responded with very low IgG2a compared to the group receiving non-adjuvanted Flu.",
            "startOffset": 19694,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        },
        {
            "endOffset": 12636,
            "parents": [],
            "secId": "s0005",
            "sentence": "That study also clearly demonstrated the versatility of the G3 technology by the incorporation of an amphipathic diterpene molecule into the G3 nanoparticle.",
            "startOffset": 12479,
            "title": "Introduction"
        },
        {
            "endOffset": 14882,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0025",
            "sentence": "Thereafter, HRP-conjugated anti-mouse IgG1 or IgG2a (Zymed, 1:1000), or total Ig (Dako, 1:1000) was added and incubated overnight at 4 \u00b0C before developed with 100 \u00b5l/well of TMB substrate (Sigma-Aldrich, St. Louis, MO, USA).",
            "startOffset": 14657,
            "title": "ELISA"
        },
        {
            "endOffset": 13966,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0020",
            "sentence": "Female BALB/c mice were housed at Karolinska Institutet, Stockholm, Sweden and handled in accordance with the guidelines of the Swedish Ethical Committee for Animal Protection.",
            "startOffset": 13790,
            "title": "Mice and immunizations"
        },
        {
            "endOffset": 25218,
            "parents": [],
            "refoffsets": {
                "b0115": {
                    "endOffset": 25123,
                    "startOffset": 25119
                },
                "b0120": {
                    "endOffset": 25217,
                    "startOffset": 25213
                }
            },
            "secId": "s0065",
            "sentence": "IL-17 is a hallmark for the Th17 response [23], which is often associated with persistent inflammation or autoimmunity in man and mouse [24].",
            "startOffset": 25077,
            "title": "Discussion"
        },
        {
            "endOffset": 20928,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0060",
            "sentence": "There was no difference in numbers of IFN-\u03b3 producing cells between the groups vaccinated with Flu or Flu-Al(OH)3.",
            "startOffset": 20814,
            "title": "Adjuvant effect on the Flu-specific cytokine responses"
        },
        {
            "endOffset": 15410,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Four HA units were used to determine the HI titre.",
            "startOffset": 15360,
            "title": "Hemagglutination-inhibition assay (HI)"
        },
        {
            "endOffset": 13132,
            "parents": [],
            "secId": "s0005",
            "sentence": "The B and T cell responses were examined by serology and by FluoroSpot analysis on single or dual cytokine secreting splenocytes obtained from mice one week after the booster immunizations.",
            "startOffset": 12943,
            "title": "Introduction"
        },
        {
            "endOffset": 16279,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Plate washing volumes were 200 \u03bcl and all other steps 100 \u03bcl if nothing else is stated.",
            "startOffset": 16192,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 17995,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "The plates were washed as described above and enzyme- or fluorophore-conjugated reagents; Streptavidin-ALP diluted 1:1000, anti-BAM-640 and Streptavidin-550 (SA-550) both diluted 1:200 in PBS/BSA were added.",
            "startOffset": 17788,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 19693,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "This pattern was also evident in their total Ig response.",
            "startOffset": 19636,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        },
        {
            "endOffset": 26503,
            "parents": [],
            "secId": "s0070",
            "sentence": "Other authors declares no conflict of interest.",
            "startOffset": 26456,
            "title": "Conflict of interest"
        },
        {
            "endOffset": 16950,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0040",
            "sentence": "Thereafter, the plates were washed five times with sterile PBS followed by 1 h blocking in cell culture medium (200 \u03bcl/well).",
            "startOffset": 16825,
            "title": "ELISpot and FluoroSpot"
        },
        {
            "endOffset": 22301,
            "parents": [],
            "refoffsets": {
                "b0070": {
                    "endOffset": 22300,
                    "startOffset": 22296
                }
            },
            "secId": "s0065",
            "sentence": "Today, most if not all non-replicating Flu vaccines are non-adjuvanted, one reason being that the aluminium hydroxide adjuvants are not well suited for influenza virus [14].",
            "startOffset": 22128,
            "title": "Discussion"
        },
        {
            "endOffset": 22911,
            "parents": [],
            "secId": "s0065",
            "sentence": "In the present comparison between G3, Al(OH)3 and the non-adjuvanted vaccine, clear differences in the IgG profiles were recorded.",
            "startOffset": 22781,
            "title": "Discussion"
        },
        {
            "endOffset": 15359,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Material and Methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The HI assay followed established protocols, using round bottomed microtiter plates (NunClon, Sigma-Aldrich) and 0.5% chicken erythrocytes (H\u00e5tunalab AB, Bro, Sweden) but using split virus vaccine, instead of intact virus particles.",
            "startOffset": 15127,
            "title": "Hemagglutination-inhibition assay (HI)"
        },
        {
            "endOffset": 20016,
            "parents": [
                {
                    "id": "s0050",
                    "title": "Results"
                }
            ],
            "secId": "s0055",
            "sentence": "Thus, both adjuvants induced the Th2 associated IgG1 subtype equally well, but only G3 enhanced the Th1 associated IgG2a subtype.",
            "startOffset": 19887,
            "title": "G3 and Al(OH)3 adjuvants enhance different serum IgG subclasses"
        }
    ],
    "docId": "S0264410X18305516",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": "Bernt.Hjertner@slu.se",
                "first": "Bernt",
                "initial": "B.",
                "last": "Hjertner"
            },
            {
                "email": "Theresa.Bengtsson@mabtech.com",
                "first": "Theresa",
                "initial": "T.",
                "last": "Bengtsson"
            },
            {
                "email": "Bror.Morein@gmail.com",
                "first": "Bror",
                "initial": "B.",
                "last": "Morein"
            },
            {
                "email": "Staffan.Paulie@mabtech.com",
                "first": "Staffan",
                "initial": "S.",
                "last": "Paulie"
            },
            {
                "email": "Caroline.Fossum@slu.se",
                "first": "Caroline",
                "initial": "C.",
                "last": "Fossum"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.04.054",
        "firstpage": "3340",
        "issn": "0264410X",
        "keywords": [
            "Adjuvant",
            "Cytokine production",
            "Influenza",
            "Th1/Th2"
        ],
        "lastpage": "3344",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "A novel adjuvant G3 induces both Th1 and Th2 related immune responses in mice after immunization with a trivalent inactivated split-virion influenza vaccine"
    }
}